Medindia7h
Novartis receives third FDA approval for oral Fabhalta (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis Media Relations E-mail: [email protected] Novartis Investor Relations Central investor relations line: +41 61 ...
Le Lézard12h
Novartis receives third FDA approval for oral Fabhalta® (iptacopan) - the first and only treatment approved in C3 glomerulopathy (C3G)
Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to reduce proteinuria, ...
Fort Frances Times20h
A Sault woman’s recovery from addiction reflects a changing landscape of services
Riley McPhee spent 14 years in addiction. Last week, she celebrated nine months sober. It is often said that when an addict ...
CNET on MSN23h
Achieve a Balanced Diet by Cutting Back on These 11 Foods
You don't need to eliminate all your favorite foods to have a balanced diet -- you need to reduce your intake. Here are the ...